Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.04 (-5.56%)
Close on Nov 19, 2026Market cap $39.56MP/E –Yield –
Connect Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Connect Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$60.63M. For fiscal 2025 it was -$51.64M. The highest annual figure on record is -$24.36M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.64M | – |
| FY2024 | Dec 31, 2024 | -$24.36M | – |
| FY2023 | Dec 31, 2023 | -$47.82M | – |
| FY2022 | Dec 31, 2022 | -$105.93M | – |
| FY2021 | Dec 31, 2021 | -$88.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.27M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$591.00K | – |
See a number that looks wrong?